FTRE

Fortrea Holdings Inc. is a global contract research organization (CRO) providing clinical development and patient access services to biopharmaceutical and medical device companies. The company offers a comprehensive suite of services spanning Phase I through Phase IV clinical trials, including clinical trial management, data management, biostatistics, regulatory affairs, and medical writing. Fortrea was spun off from Labcorp in 2023 as a standalone publicly traded company. The company operates across multiple therapeutic areas and maintains a global presence with facilities and operations in numerous countries. Fortrea serves pharmaceutical and biotech companies of all sizes, from emerging biotechs to large multinational corporations.